JPMORGAN CHASE & CO

Position in SGMT — Sagimet Biosciences Inc.

CIK 19617 NEW YORK, NY

Position in SGMT

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$223,628

+$211,517 QoQ

Shares Held

28,930

+1148.1% QoQ

Ownership

0.047%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#71

of 122 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 16% Shared 0% None 84%

Healthcare · as of Jun 30, 2026

JPMORGAN CHASE & CO holds $12,940,254,031 across 424 Biotechnology names. SGMT ranks #229 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	6,517,600	$3,237,487,438
2	REGN	Regeneron Pharmaceuticals, Inc.	3,774,199	$2,353,364,036
3	INSM	INSMED Inc	10,428,170	$1,111,851,478
4	ALNY	Alnylam Pharmaceuticals, Inc.	2,675,517	$805,410,876
5	RVMD	Revolution Medicines, Inc.	3,298,066	$617,661,794
6	RYTM	Rhythm Pharmaceuticals, Inc.	2,652,746	$294,534,385
7	JAZZ	Jazz Pharmaceuticals plc	1,160,786	$279,714,596
8	QURE	uniQure N.V.	4,867,755	$224,208,791

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$223,628	28,930	+1148.1%	Shares	Defined	2026-08-12
2026-03-31	$12,111	2,318	-6.8%	Shares	Defined	2026-05-13
2025-12-31	$14,728	2,488	+2438.8%	Shares	Defined	2026-02-11
2025-09-30	$672	98	0.0%	Shares	Defined	2025-11-07
2025-06-30	$746	98	0.0%	Shares	Defined	2025-08-12
2025-03-31	$319	98	-99.8%	Shares	Defined	2025-05-12
2024-12-31	$216,288	48,064	-33.3%	Shares	Defined	2025-02-12
2024-09-30	$199,486	72,017	+66.2%	Shares	Defined	2024-12-26
2024-06-30	$148,178	43,327	-96.1%	Shares	Defined	2024-12-26
2024-03-31	$6,088,322	1,123,307	+31622.9%	Shares	Defined	2024-12-26
2023-12-31	$19,192	3,541	0.0%	Shares	Defined	2024-12-26
2023-09-30	$31,160	3,541	—	Shares	Defined	2023-11-14
No filing history on record for this holder in this stock.